Palatin Technologies Inc Cash Flow Conversion Efficiency

Latest as of March 2025: 0.838x

Palatin Technologies Inc cash flow conversion efficiency. Based on the latest financial reports, Palatin Technologies Inc (PTN) has a cash flow conversion efficiency ratio of 0.838x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.35 Million) by net assets ($-6.39 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Palatin Technologies Inc (1996–2024)

Cash flow conversion efficiency of Palatin Technologies Inc from 1996 to 2024. This chart illustrates how Palatin Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Palatin Technologies Inc (PTN) stock price for real-time trading data and today's change.

Palatin Technologies Inc Cash Flow Conversion Ratio Explained

Palatin Technologies Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Palatin Technologies Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Palatin Technologies Inc ranked by their cash flow conversion efficiency. Also see Palatin Technologies Inc (PTN) market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Check-Cap Ltd.
NASDAQ:MBAI
N/A
Spago Nanomedical AB
ST:SPAGO
-0.201x
Munic SA
PA:ALMUN
0.139x
BLACK PEARL ZY-10
F:7ZX
-0.011x
AE Multi Holdings Bhd
KLSE:7146
0.140x
Aptevo Therapeutics Inc
NASDAQ:APVO
-0.903x
Dongbu Corp
KO:005965
0.058x
UMT United Mobility Technology AG
XETRA:UMD
0.141x

Annual Cash Flow Conversion Efficiency for Palatin Technologies Inc (1996–2024)

The table below shows the annual cash flow conversion efficiency of Palatin Technologies Inc from 1996 to 2024. Review cash generation quality of Palatin Technologies Inc to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-06-30 $-111.50K $-31.46 Million 282.173x +233.12%
2023-06-30 $134.07K $-28.42 Million -211.967x -11423.83%
2022-06-30 $16.27 Million $-29.92 Million -1.839x -303.25%
2021-06-30 $49.65 Million $-22.65 Million -0.456x -188.49%
2020-06-30 $80.17 Million $41.33 Million 0.515x +337.94%
2019-06-30 $100.55 Million $-21.78 Million -0.217x -443.00%
2018-06-30 $26.96 Million $1.70 Million 0.063x +102.53%
2017-06-30 $-5.16 Million $12.88 Million -2.494x -192.61%
2016-06-30 $-17.59 Million $-47.36 Million 2.693x +346.07%
2015-06-30 $12.20 Million $-13.36 Million -1.095x +12.23%
2014-06-30 $9.79 Million $-12.21 Million -1.247x -109.95%
2013-06-30 $22.98 Million $-13.65 Million -0.594x +92.98%
2012-06-30 $1.83 Million $-15.49 Million -8.459x -1295.05%
2011-06-30 $18.19 Million $-11.03 Million -0.606x +1.39%
2010-06-30 $9.32 Million $-5.73 Million -0.615x +62.57%
2009-06-30 $3.31 Million $-5.44 Million -1.643x +47.69%
2008-06-30 $6.55 Million $-20.58 Million -3.141x -163.94%
2007-06-30 $18.53 Million $-22.05 Million -1.190x +7.13%
2006-06-30 $18.30 Million $-23.45 Million -1.281x -133.44%
2005-06-30 $9.23 Million $-5.06 Million -0.549x +55.18%
2004-06-30 $19.39 Million $-23.74 Million -1.225x -14.86%
2003-06-30 $18.66 Million $-19.89 Million -1.066x +29.55%
2002-06-30 $8.69 Million $-13.15 Million -1.513x -114.75%
2001-06-30 $11.92 Million $-8.40 Million -0.705x +43.02%
2000-06-30 $6.91 Million $-8.54 Million -1.237x +96.43%
1999-06-30 $300.00K $-10.40 Million -34.667x -1492.79%
1998-06-30 $3.40 Million $-7.40 Million -2.176x -420.23%
1997-06-30 $9.80 Million $-4.10 Million -0.418x +56.18%
1996-06-30 $2.84 Million $-2.71 Million -0.955x --

About Palatin Technologies Inc

NYSE MKT:PTN USA Biotechnology
Market Cap
$598.13 Million
Market Cap Rank
#29786 Global
#6086 in USA
Share Price
$23.00
Change (1 day)
+4.59%
52-Week Range
$17.10 - $23.00
All Time High
$41.00
About

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is… Read more